Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
Fei Zhou, Haoyue Guo, Yang Xia, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 10

Showing 10 citing articles:

Immunotherapy efficacy between exon 19 deletion and exon 21 L858R mutation in advanced EGFR mutant non-small-cell lung cancer: a direct and indirect meta-analysis
Zihong Chen, Lanlan Pang, Yang Yuwen, et al.
Translational Lung Cancer Research (2025) Vol. 14, Iss. 2, pp. 422-430
Open Access | Times Cited: 1
Analysis of the Correlation between Biological Effects of EGFR Exon 19 and 21 Mutations and Clinical and Imaging Features in Lung Adenocarcinoma
Min Li, Zhenfeng Wang, Qiang Zhang
Journal of Contemporary Medical Practice (2025) Vol. 7, Iss. 1, pp. 123-128
Closed Access
Single-Cell RNA Sequencing in Unraveling Acquired Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: New Perspectives
Peng Lin, Siyou Deng, Jinjie Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1483-1483
Open Access
Bombesin Receptor Subtype-3 Regulates Tumor Growth by HER2 Tyrosine Phosphorylation in a Reactive Oxygen Species-Dependent Manner in Lung Cancer Cells
Terry W. Moody, Irene Ramos-Álvarez, Samuel A. Mantey, et al.
Targets (2025) Vol. 3, Iss. 1, pp. 7-7
Open Access
PYCR1 Promotes Esophageal Squamous Cell Carcinoma by Interacting With EGFR to Affecting the PI3K/Akt/mTOR Signaling Pathway
Yuqi Meng, Haiming Feng, Bin Li, et al.
The Journal of Gene Medicine (2025) Vol. 27, Iss. 3
Closed Access
A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non‐Small Cell Lung Cancer
Edanur Topalan, Ahmet Büyükgüngör, Melih Çiğdem, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 4
Open Access
METTL16-dependent miR-146b-5p m6A modification remodeling sensitize NSCLC to osimertinib via activating PI3K/AKT signaling
Hongyang Sang, Jinlong Liu, Xifang Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Analysis of tumor cell proliferation (Ki-67) and cell cycle regulator proteins in lung adenocarcinoma with different radiological subtypes
Rirong Qu, Yang Zhang, Shenghui Qin, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Protein Nanoparticles Simultaneously Displaying TRAIL and EGFR-Binding Ligands Effectively Induce Apoptotic Cancer Cell Death and Overcome EGFR-TKI Resistance in Lung Cancer
Yunjung Kim, Jiwoo Kim, Soomin Eom, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
A novel tRNA-Derived Fragment, tRF-20-M0NK5Y93 inhibits the malignant progression of non-small cell lung cancer by mediating PLOD1
Lixin Wu, Xiaojie Chen, Chen Dong, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110431-110431
Closed Access
Page 1

Scroll to top